Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
ID: 351124Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/351124

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PA-23-317.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for competing revisions to existing NIH single project research grants and cooperative agreements, with a focus on clinical trials. This initiative allows eligible organizations to apply for additional funding to expand ongoing projects under specific NIH Institutes or Centers, following the guidelines set forth in the Notice of Special Interest (NOSI). The application process is electronic, requiring submissions via the NIH ASSIST system or Grants.gov, and will be evaluated based on scientific merit, innovation, and relevance to NIH priorities. Interested applicants must submit their proposals by November 24, 2026, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov for further assistance.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PA-23-317.html
    The National Institutes of Health (NIH) is announcing a funding opportunity for revision applications to expand existing NIH single project research grants and cooperative agreements, particularly those related to clinical trials. The funding aims to allow organizations to apply for additional support to enhance ongoing projects under specified Institutes or Centers. This announcement, titled PA-23-317, follows several related Notices of Special Interest (NOSIs) that detail the eligibility and types of applications accepted. Eligible applicants include a wide range of organizations, from higher education institutions to non-profits and local governments. The application process is electronic, requiring submission via the NIH ASSIST system or Grants.gov. Review criteria will assess the significance, investigator qualifications, innovation, approach, and the environment of proposed projects. Final funding decisions will be based on scientific merit, relevance to NIH priorities, and available funds. The expiration date for applications is November 24, 2026, and applicants are urged to submit applications early to correct potential errors. This funding opportunity reflects NIH's commitment to advancing scientific research through collaborations and innovative project expansions.
    Similar Opportunities
    Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for organizations holding specific types of NIH grants to submit applications for changes in recipient organization status, known as Successor-in-Interest. This initiative aims to facilitate transitions for organizations while ensuring project continuity, allowing eligible applicants—including various higher education institutions, nonprofits, government entities, and foreign organizations—to propose research that aligns with the original NIH-supported project scope. Applications will undergo an administrative evaluation focusing on compliance with federal regulations, with key dates including an open submission period starting July 19, 2024, and a funding expiration date set for July 18, 2027. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced an urgent funding opportunity for competitive revisions to existing research grants aimed at addressing immediate public health crises. This initiative allows Principal Investigators holding specific NIH grants to apply for additional funding to meet unforeseen needs related to public health emergencies, with applications routed directly to the relevant NIH awarding component. The program emphasizes support for diverse institutions, including historically underrepresented entities, and aims to enhance research capacity in critical health areas. Interested applicants can find more details and submit inquiries via grantsinfo@nih.gov, with proposals due by October 25, 2025, under the funding opportunity announcement PA-23-044.
    Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for organizations seeking to change the recipient organization of specific NIH grants. This initiative allows eligible applicants, including higher education institutions, nonprofits, and various government entities, to submit applications for the transfer of grant awards, ensuring continuity in research projects. While the submission of applications does not guarantee approval for the transfer, the NIH encourages coordination with relevant institutes and adherence to grant policies to facilitate a smooth transition. Interested parties can find more information and submit inquiries via email at grantsinfo@nih.gov, with key submission dates starting from July 12, 2024, and the opportunity closing on July 12, 2027.
    Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced an Emergency Competitive Revision program aimed at providing funding for applications related to disasters declared under the Stafford Act or public health emergencies. This initiative is designed to support existing NIH awards and facilitate projects that address urgent public health issues stemming from such emergencies. Eligible applicants include a diverse range of organizations, such as higher education institutions, nonprofits, and local governments, particularly those impacted by recent disasters. The funding opportunity, designated as PA-24-201, opens on April 19, 2024, with applications due by April 18, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PA-24-201.html.
    Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for revision applications aimed at validating biomarker assays developed through NIH-supported research grants, specifically under the R01 mechanism, with a focus on enhancing their clinical application for cancer detection and treatment. This initiative seeks to accelerate the translation of molecular, cellular, and imaging markers into clinical settings, encouraging multidisciplinary collaborations among scientists, clinicians, and laboratory experts to adapt and validate these biomarkers for various cancer-related purposes. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with funding available up to $150,000 for a project period of up to three years. Interested parties should note that the application deadline is October 13, 2026, and can find further details and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required), inviting applications for long-term clinical trials lasting 6 or 7 years. These trials must be hypothesis-driven, aligned with NIH's research mission, and include clearly defined objectives and milestone planning to monitor progress. This initiative emphasizes the importance of extended clinical trials in advancing critical biomedical research, with no specific budget limits but requiring justification based on project needs. Interested applicants must consult with NIH staff prior to submission, adhere to new application forms and data sharing policies, and submit their applications by January 13, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-084.html.
    NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Notice of Funding Opportunity (NOFO) for the NIAID Clinical Trial Implementation Cooperative Agreement (U01), aimed at supporting high-risk clinical trials that enhance the understanding of human diseases. This funding opportunity encourages applications for investigator-initiated, milestone-driven clinical trials, with each application permitted to propose only one clinical trial that must demonstrate a hypothesis-driven approach. The initiative emphasizes the importance of mechanistic studies within clinical trials and requires a robust plan for managing trial complexity and participant safety. Interested applicants can find additional details and guidelines at the provided NIH link, with the earliest submission date set for April 12, 2024, and the application deadline on January 13, 2027. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (FON PAR-24-099) aimed at small business concerns proposing investigator-initiated clinical trials that align with the NIAID's research mission. This program supports hypothesis-driven and milestone-driven clinical trials, particularly those classified as high-risk, which may involve unique interventions or the use of licensed products for unapproved indications. The initiative underscores the government's commitment to advancing innovative clinical research to address significant healthcare challenges, with funding of up to $1 million annually available for meritorious applications. Interested applicants must adhere to strict guidelines and submit their applications by the various deadlines, with the first due date on April 12, 2024, and the final deadline on January 13, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) to support discrete scientific projects aligned with the interests of various NIH Institutes and Centers. This grant is specifically designed for projects that do not involve clinical trials, focusing instead on advancing health-related research and development. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with no fixed budget limits, although applicants must justify their requested funding. Interested parties should note that the application deadline is January 7, 2025, and can find more information by contacting the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visiting the official announcement at http://grants.nih.gov/grants/guide/pa-files/PA-20-185.html.
    NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) for renewal and competing revision applications focused on aging research, designated as U01 Clinical Trial Optional. This initiative aims to support research projects that address critical issues related to aging, including Alzheimer's disease and related dementias, thereby facilitating advancements in public health. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, for-profit entities, governmental agencies, and foreign institutions, with no cost-sharing or matching requirements. Interested parties should note that applications are due by October 1, 2024, and can find further details and application guidelines at the NIH website or by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov.